# ACL-R Opioid Sparing Study

> **NCT06561035** · PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Campbell Clinic** · enrollment: 56 (estimated)

## Conditions studied

- Anterior Cruciate Ligament Injuries

## Interventions

- **DRUG:** Opiate Sparing
- **DRUG:** Opiate Based

## Key facts

- **NCT ID:** NCT06561035
- **Lead sponsor:** Campbell Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-09-01
- **Primary completion:** 2025-08
- **Final completion:** 2026-06
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2024-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06561035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06561035, "ACL-R Opioid Sparing Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06561035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*